Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.81%
1,077.99
-19.82
-1.81%
1,097.811,087.761,087.761,077.51
SIXC
Communications
SIXC
Communications
SIXC
-0.36%
609.82
-2.21
-0.36%
612.03612.03612.03609.71
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,232.14
+11.71
+0.96%
1,220.431,221.991,234.271,221.99
SIXI
Industrials
SIXI
Industrials
SIXI
-1.63%
1,730.79
-28.31
-1.63%
1,759.521,754.311,754.311,729.03
SIXM
Financials
SIXM
Financials
SIXM
-0.20%
630.26
-1.28
-0.20%
631.54631.27633.91630.26
SIXR
Staples
SIXR
Staples
SIXR
+0.18%
858.73
+1.57
+0.18%
857.16858.91861.71858.73
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.92%
213.43
-1.98
-0.92%
215.41215.41215.41213.07
SIXT
Technology
SIXT
Technology
SIXT
-2.05%
3,540.06
-74.09
-2.05%
3,614.153,556.243,556.243,535.56
SIXU
Utilities
SIXU
Utilities
SIXU
-1.08%
898.45
-9.85
-1.08%
908.30906.55906.55897.14
SIXV
Health care
SIXV
Health care
SIXV
+0.06%
1,481.32
+0.92
+0.06%
1,480.401,479.551,484.431,479.55
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.59%
2,360.25
-38.12
-1.59%
2,398.372,373.092,373.092,358.97
RIGL:NASDAQ
Rigel Pharmaceuticals Inc
$31.52
-1.25%
(-0.40) 1D
May 15, 9:39:39 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RIGL...
Open
$31.92
High
$32.89
Low
$31.50
Mkt. cap
595.03M
Avg. vol.
416.21K
Volume
32.73K
P/E ratio
1.71
52-wk high
$52.24
52-wk low
$18.14
EPS
$18.43
Beta
1.21
Shares outstanding
18.50M
No. of employees
173
News stories
From sources across the web
About Rigel Pharmaceuticals Inc
CEO-
Employees173
Founded1996
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiterigel.com
Last report
May 5, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$0.44 / $1.02
-56.99%miss
Revenue / Est. (USD)
58.82M / 62.92M
-6.52%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
101.68M
69.46M
69.80M
58.82M
Cost of goods sold
11.32M
12.11M
16.64M
16.28M
Cost of revenue
11.32M
12.11M
16.64M
16.28M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.26M
28.94M
29.99M
30.65M
Operating expense
29.26M
28.94M
29.99M
30.65M
Total operating expenses
40.58M
41.04M
46.63M
46.93M
Operating income
61.10M
28.42M
23.17M
11.88M
Other non operating income
-
-
-
-
EBT including unusual items
59.98M
27.62M
22.71M
11.66M
EBT excluding unusual items
59.98M
27.62M
22.71M
11.66M
Income tax expense
369.00K
-280.00K
-245.35M
3.00M
Effective tax rate
0.62%
-1.01%
-1,080.18%
25.76%
Other operating expenses
-
-
-
-
Net income
59.61M
27.90M
268.06M
8.65M
Net profit margin
58.63%
40.17%
384.04%
14.71%
Earnings per share
3.28
1.46
1.12
0.44
Interest and investment income
753.00K
1.09M
1.24M
1.20M
Interest expense
-1.87M
-1.89M
-1.70M
-1.43M
Net interest expenses
-1.12M
-800.00K
-456.00K
-228.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
61.71M
29.02M
23.77M
12.48M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more